Question
Which diagnostics and biomarkers show reproducible clinical utility across populations and care settings?
SourcePress of International Journal of Ophthalmology (IJO Press)SourceMultidisciplinary Digital Publishing InstituteWhich diagnostics and biomarkers show reproducible clinical utility across populations and care settings?
Which diagnostics and biomarkers show reproducible clinical utility across populations and care settings?
SourcePress of International Journal of Ophthalmology (IJO Press)SourceMultidisciplinary Digital Publishing InstituteDiagnostic value depends on validation, accessibility, and decision impact.
SourcePress of International Journal of Ophthalmology (IJO Press)SourceMultidisciplinary Digital Publishing InstituteMulti-omics, liquid biopsy, and AI diagnostics are moving toward clinical workflows.
SourcePress of International Journal of Ophthalmology (IJO Press)SourceMultidisciplinary Digital Publishing InstituteDiscovery is abundant, while durable clinical utility is harder to prove.
SourcePress of International Journal of Ophthalmology (IJO Press)SourceMultidisciplinary Digital Publishing InstituteTrack studies and registry updates with validation and population details. Evidence candidates are attached from recent source-backed outputs in this topic.
SourcePress of International Journal of Ophthalmology (IJO Press)SourceMultidisciplinary Digital Publishing InstituteA Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph... (NCT05621291)
Oculomics: advances and perspectives from traditional Chinese medicine to modern multimodal biomarkers
Emerging Biomarkers in Pediatric Food Allergy: From Mechanistic Endotyping to Precision Diagnosis and Therapeutic Monitoring